Status:
COMPLETED
Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 2)
Lead Sponsor:
Cambridge Health Alliance
Collaborating Sponsors:
The Arthur Vining Davis Foundations
The Arnold P. Gold Foundation
Conditions:
Depression
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Among primary care patients, compare the effectiveness of an 8-week mindfulness-based intervention (Mindfulness Training for Primary Care\[MTPC\]) vs. a low-dose mindfulness introduction comparator on...
Detailed Description
This study builds on a pilot study that investigated the impact of Mindfulness Training for Primary Care on anxiety, depression, stress, and chronic illness self-management in primary care patients re...
Eligibility Criteria
Inclusion
- Current CHA patient with an enrolled CHA primary care doctor.
- CHA patients 18 years of age and older.
- Able to tolerate and participate in interviews and engage in all procedures.
- Able to give written consent in English OR willing and able to provide consent and complete assessments through a professional language translator when necessary.
- Diagnosis eligible to be covered by insurance for group visits (e.g., anxiety disorder, depression, or adjustment disorder related to chronic illness, pain, etc.).
Exclusion
- Any cognitive impairment that precludes informed consent.
- Patients who, in the opinion of the Principal Investigator, pose an imminent risk of suicide or danger to self or others.
- Likelihood of potential incarceration such as a conviction or pending charges that may potentially result in imprisonment.
- Previous enrollment or randomization of treatment in the present study within the 12 months.
- Behaviors that may cause disruption to a mindfulness group.
- Patients with symptoms of psychosis, thought disorder, and/or severe mental illness, including schizophrenia, schizoaffective, bipolar disorder, or a current severe episode of major depressive disorder.
- Lack of insurance coverage for group psychotherapy may preclude participation in groups.
- Patients in their third trimester of pregnancy who foresee conflicts that preclude their commitment to completing all activities.
- Patients with highly unstable medical problems that put them at a high risk of hospitalization.
Key Trial Info
Start Date :
February 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT03265600
Start Date
February 1 2017
End Date
August 1 2020
Last Update
November 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cambridge Health Alliance
Somerville, Massachusetts, United States, 02143